Professional Documents
Culture Documents
discussions, stats, and author profiles for this publication at: http://www.researchgate.net/publication/223958463
CITATIONS
READS
370
1 AUTHOR:
Robert Ross
Detroit Medical Center
54 PUBLICATIONS 843 CITATIONS
SEE PROFILE
Pediatr Cardiol
DOI 10.1007/s00246-012-0306-8
ORIGINAL ARTICLE
R. D. Ross (&)
Division of Pediatric Cardiology, Carmen and Ann Adams
Department of Pediatrics, Childrens Hospital of Michigan,
Wayne State University School of Medicine,
3901 Beaubien Blvd., Detroit, MI 48201, USA
e-mail: rross@dmc.org
123
Pediatr Cardiol
Table 1 Original Ross classification [16]
I: No limitations or symptoms
II: Mild tachypnea or diaphoresis with feedings in infants, dyspnea
at exertion in older children; no growth failure
III: Marked tachypnea or diaphoresis with feedings or exertion and
prolonged feeding times with growth failure from CHF
IV: Symptomatic at rest with tachypnea, retractions, grunting, or
diaphoresis
the study, which may have been too early for growth
failure from HF to have become manifest.
Several authors have modified the aforementioned
scoring system to expand its use to older children. The first
such attempt was by Reithmann et al. [14] in their study on
adenylyl cyclase in severe HF. They added basal heart and
respiratory rates for children by age, namely, for infants
and children 16 years old, children 710 years old, and
children 1114 years old. This was a useful modification,
but these authors also reinstituted diaphoresis and added
cyanosis and a precordial thrill, neither of which are typically associated with HF. In 2002, Laer et al. [10] modified
this further, limiting their new version to six variables
(Table 3). A potential downside of this simplified version
is that half of the six categories relate to the work of
breathing, which may undervalue the other manifestations
of congestive heart failure (CHF) in children. Nevertheless,
many subsequent studies have used this Laer-modified
Ross scoring system to study HF.
At about the same time, a new system called the New
York University Pediatric Heart Failure Index (PHFI) was
proposed by Connelly et al. [4]. This 30-point scale uses
many of the signs and symptoms in the Ross classification
but adds points for medications used to treat HF and also
for a single-ventricle physiology. Although sicker patients
generally do require more medications, scoring in this way
may be problematic. If a child with severe symptoms of HF
is treated and the symptoms improve, the change in score
?1
?2
Diaphoresis
Head only
Head and
body at rest
Tachypnea
Rare
Several times
Frequent
Retractions
Dyspnea
History
Table 2 Ross scoring system for heart failure in infants [17]
Score
0
Breathing
Feeding history
Volume consumed per feeding (oz)
[3.5
2.53.5
\2.5
\40
[40
Physical exam
Respiratory rate (n/min)
\50
5060
[60
\160
160170
[170
Respiratory pattern
Normal
Abnormal
Peripheral perfusion
Normal
Decreased
S3 or diastolic rumble
Absent
Present
23
[3
123
Physical examination
Normal
Age (years)
Respiratory rate (breaths/min) (years)
01
\50
5060
[60
16
\35
3545
[45
710
\25
2535
[35
1114
\18
1828
[28
\160
160170
[170
16
\105
105115
[l15
710
\90
90100
[100
1114
\80
8090
[90
\2
23
[3
Hepatomegaly
size (cm)
Pediatr Cardiol
cardiomyopathy and found that in a 4-year follow-up period, the percentage of peak oxygen consumption (based on
age and sex) stratified outcomes accurately. Using 62 % of
predicted normal as a cutoff, survival curves indicated a
significantly higher rate of death or urgent listing for
transplantation of 50.6 (for those B62 %) versus 4.4 %
(for those [62 %) at 24 months, with a hazard ratio of
10.8.
Growing evidence also indicates that poor systolic
function bodes ill in terms of long-term outcomes for
children as it does for adults. In both dilated cardiomyopathy and HF from congenital heart disease, low ejection
fractions predict death or the need for transplantation
[9, 12].
It is clear that with all this recent data on factors
predictive of outcomes in children with HF that a revision
in how we grade symptom severity is required. It also is
apparent that an age stratification is required to encompass the changes in signs and symptoms that children
manifest from infancy to late childhood. A classification
system should include the biomarkers, echo parameters of
systolic function and mitral or systemic atrioventricular
valve (AV) insufficiency, and reflect exercise limitations
reflected by feeding and growth in infants and exercise
capacity indicated by percentage of predicted maximal oxygen uptake (VO2) in older children. Therefore, I
propose an age-based Ross classification using the original variables that proved to be sensitive and specific and
adding the new evidence-based data. Table 4 depicts this
revised system.
The age ranges of 03 months, 412 months, 13 years,
48 years, and 918 years were chosen because the variables in the classification are generally stable during these
periods but vary between them. Each age range has 10
variables with scores of 0, 1, or 2 possible for a range of 0
to 20. The scoring system can be used as a continuous data
set for comparison with outcomes, or it can be categorized
by points assessed as Ross classes I (05), II (610), III
(1115) and IV (1620).
For all children, hepatomegaly is measured as the distance below the right costal margin with abdominal situs
solitus or from the left costal margin for situs inversus. The
ejection fraction generally is obtained from echocardiography but can be derived from MRI or other imaging
methods for single ventricles or systemic right ventricles.
Systemic AV insufficiency refers to the mitral valve for
systemic left ventricles and to the systemic AV valve for
single ventricles or systemic right ventricles.
Each age range has unique aspects that require comment. All heart rate and respiratory rates should be recorded with the infant or child in the basal state without crying
or undo agitation, and the cutoff points have been selected
based on normals for these age ranges [19].
123
Pediatr Cardiol
Table 4 Age-based Ross classification for heart failure in children
0
Oz/feeding
[3.5
2.53.5
\2.5
\20
2040
[40
Breathing
Nl
Tachypnea
Retractions
RR/min
\50
5060
HR/min
\160
Perfusion
Hepatomegaly (cm)
Table 4 continued
0
N/V
Nl
Intermittent
Frequent
Breathing
Nl
Tachypnea
Retractions
RR/min
\20
2030
[30
HR/min
\90
90100
[100
[60
Perfusion
Nl
Reduced
Shocky
160170
[170
Hepatomegaly (cm)
\2
23
[3
Nl
\2
Reduced
23
Shocky
[3
NT-proBNP (pg/ml)
\300
3001,500
[1,500
EF%
[50
3050
\30
NT-proBNP (pg/ml)
\450
([4 days)
4501,700
[1,700
Max %VO2
[80
6080
\60
EF%
[50
3050
\30
AV insufficiency
None
Mild
Moderate/
severe
AV insufficiency
None
Mild
Moderate/
severe
Feeding
Nl
Decreased
Gavaged
Wt%
Breathing
Nl
Nl
C1 Curve
Tachypnea
C2 Curve
Retractions
RR/min
\40
4050
[50
HR/min
\12
120130
[130
Perfusion
Nl
Reduced
Shocky
Hepatomegaly (cm)
\2
23
[3
NT-proBNP (pg/ml)
\450
4501,700
[1,700
EF%
[50
3050
\30
AV insufficiency
None
Mild
Moderate/
severe
Feeding
Nl
Decreased
Gavaged
Growth
Breathing
Nl
Nl
Weight loss
Tachypnea
Cachexia
Retractions
RR/min
\30
3040
[40
HR/min
\110
110120
[120
Perfusion
Nl
Reduced
Shocky
Hepatomegaly (cm)
\2
23
[3
03 Months
918 Years
412 Months
Age 03 Months
The volume of formula per feeding is for bottle-fed babies.
For breastfed infants, the volume taken has to be rated
subjectively as normal, decreased, or gavage supplemented. Normally, NT-proBNP is elevated in newborns, so
this measurement should be obtained after 4 days of life.
13 Years
NT-proBNP (pg/ml)
\450
4501,700
[1,700
EF%
[50
3050
\30
AV insufficiency
None
Mild
Moderate/
severe
48 Years
N/V
None
Intermittent
Frequent
Growth
Nl
Weight loss
Cachexia
Breathing
RR/min
Nl
\25
Tachypnea
2535
Retractions
[35
HR/min
\100
90100
[100
Perfusion
Nl
Reduced
Shocky
Hepatomegaly (cm)
\2
23
[3
NT-proBNP (pg/ml)
\300
3001,500
[1,500
EF%
[50
3050
\30
AV insufficiency
None
Mild
Moderate/
severe
123
Age 13 Years
Because the time of early rapid growth has passed by these
ages, the pattern on the growth curves has been changed to
recent weight loss and cachexia for respectively 1 and 2
points.
Pediatr Cardiol
Age 48 Years
As children age, their gastrointestinal symptoms from HF
change to reports of nausea or vomiting, so scores are 1 for
these symptoms intermittently and 2 for frequent nausea or
vomiting. The cutoff values for NT-proBNP have been
adjusted down for the lower values found after the age of
3 years.
References
Age 918 Years
At this age, most children can perform a maximal stress
test, so this has replaced growth failure as a more objective
measure of heart failure decompensation.
BNP
Although NT-proBNP has a longer half-life than BNP and
correlates better with symptom class, retrospective studies
may have access only to BNP levels. If so, then BNP may
replace NT-proBNP in the grid for all ages beyond 4 days,
with points of 0 for less than 30 pg/ml, 1 for 30140 pg/ml,
and 2 for more than 140 pg/ml. Because these peptides also
may be elevated from renal dysfunction, children with
advanced renal insufficiency may have a somewhat inflated
score for this component [21].
Class IV
Finally, some children will be so sick from HF that they
will require intravenous medications, circulatory support
such as extracorporeal membrane oxygenation (ECMO) or
a ventricular assist device, and mechanical ventilation.
These interventions make the children unfit for the use of
this grading system and should put them by definition into
class IV.
Future Challenges
The next challenge is to test this age-based Ross classification using large numbers of infants and children with and
without overt HF to determine whether it accurately predicts outcomes for each age range. Although it does entail
more information gathering than the original Ross system,
most patients with HF get tested for these variables in
addition to the readily obtained historical and physical
examination findings. Use of this age-based stratification
should allow for more accurate grading, eliminating
the variance previously encountered based on age-related
123
Pediatr Cardiol
15.
16.
17.
18.
19.
20.
123